Jennison Associates’s LifePoint Health, Inc. LPNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-578,072
Closed -$32.8M 858
2016
Q4
$32.8M Sell
578,072
-542,558
-48% -$31.4M 0.04% 336
2016
Q3
$66.4M Sell
1,120,630
-58,929
-5% -$3.54M 0.07% 235
2016
Q2
$77.1M Sell
1,179,559
-280
-0% -$19K 0.08% 209
2016
Q1
$81.7M Buy
1,179,839
+63,785
+6% +$4.26M 0.09% 197
2015
Q4
$81.9M Buy
1,116,054
+27,657
+3% +$1.97M 0.08% 213
2015
Q3
$77.2M Buy
1,088,397
+575,119
+112% +$46.7M 0.08% 221
2015
Q2
$44.6M Buy
513,278
+159,663
+45% +$12.1M 0.04% 357
2015
Q1
$26M Sell
353,615
-7,623
-2% -$541K 0.02% 413
2014
Q4
$26M Sell
361,238
-22,515
-6% -$1.56M 0.02% 414
2014
Q3
$26.6M Sell
383,753
-43,197
-10% -$3.04M 0.02% 413
2014
Q2
$26.5M Sell
426,950
-6,977
-2% -$409K 0.02% 408
2014
Q1
$23.7M Sell
433,927
-7,199
-2% -$385K 0.02% 426
2013
Q4
$23.3M Sell
441,126
-13,997
-3% -$703K 0.02% 428
2013
Q3
$21.2M Sell
455,123
-18,890
-4% -$904K 0.02% 429
2013
Q2
$23.2M Buy
+474,013
New +$22.7M 0.03% 410

Other funds holding LPNT

Jennison Associates's LPNT Position: Q1 2017 in Review

Jennison Associates sold out of LifePoint Health, Inc. (LPNT) in Q1 2017, closing a stake of 578,072 shares — an estimated $32.8M sold.

Jennison Associates first reported a position in LPNT in Q2 2013 and held it in 15 quarters. The position peaked at $81.9M in Q4 2015. 223 funds tracked by Wall St. Rank hold LPNT as of Q1 2017.

  • Jennison Associates reported no remaining LifePoint Health, Inc. position as of Q1 2017 after selling out during the quarter.
  • Jennison Associates sold 578,072 LifePoint Health, Inc. shares in Q1 2017, an estimated $32.8M.
  • Jennison Associates first reported a position in LifePoint Health, Inc. in Q2 2013 and held it in 15 quarters.
  • Jennison Associates's LifePoint Health, Inc. position peaked at $81.9M in Q4 2015.
  • 223 funds tracked by Wall St. Rank held LifePoint Health, Inc. as of Q1 2017.

Based on Jennison Associates's 13F filing for Q1 2017, filed 28 Apr 2017.